Search

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

… Wednesday, February 20, 2013 Summary Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research. Charles L. Sawyers , Chair of Memorial Sloan Kettering’s Human Oncology

Researchers from MSK are leading the effort to develop artificial intelligence tools for the detection of the most serious form of skin cancer.

… Thursday, July 15, 2021 Melanoma is by far the most serious form of skin cancer. It’s diagnosed in about 105,000 people in the United States every year, and more than 7,000 Americans die from it annually. But when it’s caught and treated early, the disease is almost always curable. That’s why it’s important

When we talk about cancer, we often speak about “battling” or “fighting” it, writes psychiatrist William Breitbart. But a more useful mindset may focus less on combat and more on bravery, especially the courage to live, love, and care, despite the disease.

… Wednesday, August 2, 2017 Summary Cancer is not a single disease. And there is no single way to talk about it, whether the conversation is taking place around the family dinner table or roaring across the television screen. But some ways of thinking and talking about cancer can be more helpful than others

As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.

… Tuesday, May 26, 2020 As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.

… Sunday, December 2, 2018 Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.

… Tuesday, July 12, 2022 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have used DNA testing and other methods to identify a previously uncharacterized subtype of small cell lung cancer (SCLC) . As they report in a study published July 6, 2022 , in the journal Clinical Cancer Research , the

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.

… Friday, October 1, 2010 Summary A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer. A team of clinicians and computational biologists have compiled the largest catalog to date of genetic

A new pilot study by investigators at Memorial Sloan Kettering Cancer Center found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.

… Thursday, March 6, 2008 A new pilot study by investigators at Memorial Sloan Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a “dose-dense” regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown

MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry.

… Friday, August 27, 2021 Forbes has named MSK one of America’s Best-In-State Employers 2021 . MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry. Earlier this year, Forbes ranked MSK #17 on its list of America’s Best Employers for

Thanks to MSK’s expertise in treating young people with cancer, 16-year-old high school athlete Sammy is back to doing what he loves.

… Thursday, June 13, 2024 Today Sammy C. is a healthy 16-year-old boy — a top varsity athlete who plays three sports. But only 18 months ago, his life was very different. Sammy was dealing with a neuroendocrine tumor , a rare and aggressive cancer, in the lower part of his colon. He and his family sought